What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary scientific interests are in Internal medicine, Transplantation, Surgery, Gastroenterology and Immunology.
His Internal medicine study frequently draws connections between related disciplines such as Oncology.
His work carried out in the field of Transplantation brings together such families of science as Regimen, Transplantation Conditioning and Bone marrow.
Richard E. Champlin has included themes like Stem cell and Rituximab in his Surgery study.
His study focuses on the intersection of Gastroenterology and fields such as Imatinib mesylate with connections in the field of Vincristine, Philadelphia chromosome and Acute lymphocytic leukemia.
The concepts of his Immunology study are interwoven with issues in Cytotoxic T cell, Disease and Pneumonia.
His most cited work include:
- Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. (1155 citations)
- Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy (1097 citations)
- Bone Marrow-derived Mesenchymal Stem Cells as Vehicles for Interferon-β Delivery into Tumors (829 citations)
What are the main themes of his work throughout his whole career to date?
Richard E. Champlin mainly investigates Internal medicine, Transplantation, Surgery, Hematopoietic stem cell transplantation and Gastroenterology.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Oncology.
His Transplantation research incorporates elements of Leukemia, Immunology, Bone marrow and Stem cell.
His biological study spans a wide range of topics, including Preparative Regimen and Multiple myeloma.
His work deals with themes such as Survival rate, Transplantation Conditioning, Retrospective cohort study and Univariate analysis, which intersect with Hematopoietic stem cell transplantation.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Chemotherapy regimen, Tacrolimus, Cumulative incidence, Rituximab and ThioTEPA.
He most often published in these fields:
- Internal medicine (59.79%)
- Transplantation (45.49%)
- Surgery (33.57%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (59.79%)
- Transplantation (45.49%)
- Oncology (24.39%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Gastroenterology.
In his study, Minimal residual disease is strongly linked to Surgery, which falls under the umbrella field of Internal medicine.
His study on Transplantation also encompasses disciplines like
- Stem cell which is related to area like Cancer research,
- Immunology together with Cytotoxic T cell.
His Oncology research focuses on subjects like Leukemia, which are linked to Myeloid and Survival rate.
His studies in Hematopoietic stem cell transplantation integrate themes in fields like Incidence, Retrospective cohort study, Transplantation Conditioning, Cohort and Acute leukemia.
His Gastroenterology study combines topics from a wide range of disciplines, such as Methotrexate and Cumulative incidence.
Between 2015 and 2021, his most popular works were:
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors (305 citations)
- Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells (254 citations)
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity (232 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Chemotherapy
Richard E. Champlin mostly deals with Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Oncology and Immunology.
His Internal medicine study incorporates themes from Gastroenterology and Surgery.
In the field of Surgery, his study on Clinical endpoint overlaps with subjects such as Adenine nucleotide.
His studies deal with areas such as Regimen, Cyclophosphamide, Fludarabine and Stem cell as well as Transplantation.
The various areas that he examines in his Hematopoietic stem cell transplantation study include Incidence, Graft-versus-host disease, Transplantation Conditioning and Autologous stem-cell transplantation, Multiple myeloma.
His Oncology research incorporates themes from Cancer, Survival rate, Myelodysplastic syndromes, Leukemia and Survival analysis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
